In the present study, we hypothesized that IFN-α treatment resulted in depression through the inhibition of p11 and subsequent reduction of the density of 5-HTR1b/4 in nerve synapses of brain’s certain areas which were associated with depression, thereby causing nervous system dysfunction and, ultimately, depression. Here, IFNA2 is linked to depressive symptom measurement.